HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An amphipathic sequence in the cytoplasmic tail of HIV-1 Env alters cell tropism and modulates viral receptor specificity.

Abstract
The human immunodeficiency virus type 1 (HIV-1) 92UG046 Env protein, obtained from a CD4-independent HIV-1 primary isolate (Zerhouni et al., 2004), has the ability to initiate an infection in HeLa cells expressing CD4 when carrying the full-length (FL) Env, but uses CD8 molecules for receptor-mediated entry when carrying a truncated Env (CT84). To determine whether a specific length or structure in the cytoplasmic tail (CT) is responsible for this alteration of tropism, we compared a series of Env constructs with different CT truncations and the presence or absence of an amphipathic alpha- helical sequence. We found that truncated constructs containing the alpha-helical LLP-2 structure in their CT domains conferred a switch from CD4 to CD8 tropism. The results support the conclusion that the structure of the CT domain can play an important role in determining receptor specificity.
AuthorsA N Vzorov, C Yang, R W Compans
JournalActa virologica (Acta Virol) Vol. 59 Issue 3 Pg. 209-20 (Sep 2015) ISSN: 0001-723X [Print] Slovakia
PMID26435143 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Receptors, HIV
  • env Gene Products, Human Immunodeficiency Virus
Topics
  • Amino Acid Sequence
  • Animals
  • Cells, Cultured
  • Cytoplasm (chemistry)
  • HIV-1 (physiology)
  • Humans
  • Mice
  • Molecular Sequence Data
  • Protein Structure, Tertiary
  • Receptors, HIV (physiology)
  • Tropism
  • env Gene Products, Human Immunodeficiency Virus (chemistry, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: